INM - inmedpharma.com Net Margin

InMed Pharmaceuticals Inc (INM) - corporate logo

InMed Pharmaceuticals (INM) is struggling against pressure from traditional painkillers and legal barriers. The net margin dynamics on the GURU.Markets chart confirm this, with the current value standing at -1657.70. A strategic alliance with clinics to develop rare molecules enhances its investment appeal, although a narrow specialization in biosynthesis makes business success dependent on patent rulings.

InMed (INM) - Net Profit Rate from 07/04/2022 to 11/09/2026

InMed (INM) - metric breakdowns and financial figures

- share price and consensus valuation forecast:
- market capitalization statistics:
Basic company analysis:inmedpharma.com - INM
Manufactured product of InMed Pharma

Sales margins measure the share of net profit in every dollar of revenue, determining overall operational efficiency. This ratio allows an investor to assess the business's resilience to rising costs. An analysis of the net margin of core operations reveals critical profitability dips in real time. For InMed Pharmaceuticals (INM), this is critical, as sanction risks in raw material supplies directly impact profitability.